SCHEMBL14075202

SCHEMBL14075202

Cc1ccc(S(=O)(=O)Nc2ccc(Cc3ccc(NS(=O)(=O)c4ccc(C)cc4)c(C(=O)O)c3)cc2O)cc1

nearest known ligand 0.62

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ METAP2 P50579 7/20 0.62
▸ CYP2C9 P11712 2/20 0.60
▸ CYP1A2 P05177 1/20 0.60
▸ HSD17B2 P37059 1/20 0.51
▸ LMNA P02545 2/20 0.51
▸ HTT P42858 2/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ PTGDR2 Q9Y5Y4 1/20 0.49
▸ MCL1 Q07820 1/20 0.49
▸ ALDH1A1 P00352 3/20 0.49
▸ GAA P10253 1/20 0.49
▸ GFER P55789 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.48
▸ TP53 P04637 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14087834 0.94 METAP2 (0.70) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL13034766 0.88 METAP2 (0.62) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL13034755 0.87 METAP2 (0.61) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL13034757 0.86 METAP2 (0.60) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL3980105 0.85 METAP2 (0.81) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL12570805 0.82 METAP2 (0.86) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL13034754 0.81 FFAR4 (0.60) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL13034736 0.80 METAP2 (0.53) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL16496289 0.79 METAP2 (0.75) METAP2CYP2C9CYP1A2LMNAHTT
SCHEMBL5181886 0.77 HSD17B2 (0.78) METAP2CYP2C9HSD17B2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429677-B2 Small molecule entry inhibitors TIBOTEC PHARMACEUTICALS LTD. (IE) 2008-09-30 — — US disclosed
Send feedback